International Trade Commission December 22, 2020 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Certain Botulinum Toxin Products, Processes for Manufacturing or Relating to Same and Certain Products Containing Same Commission Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and a Cease and Desist Order; Termination of the Investigation
Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 in the above-captioned investigation. The Commission has determined to issue a limited exclusion order (``LEO'') prohibiting the importation by respondents Daewoong Pharmaceuticals Co., Ltd. (``Daewoong'') of Seoul, South Korea and Evolus, Inc. (``Evolus'') of Irvine, California (collectively, ``Respondents'') of certain botulinum toxin products, processes for manufacturing or relating to same and certain products containing same. The Commission has also issued a cease and desist order (``CDO'') directed to respondent Evolus. The investigation is terminated.
Twist Ties From China; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-649 and 731-TA-1523 (Final) pursuant to the Tariff Act of 1930 (``the Act'') to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of twist ties from China, provided for in subheadings 8309.90.0000 and 5609.00.3000 of the Harmonized Tariff Schedule of the United States, preliminarily determined by the Department of Commerce (``Commerce'') to be subsidized and sold at less-than-fair-value.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
